Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors

Journal of General Virology

Volumn 86, Issue 10, 2005, Pages 2787-2792

  Naka, Kazuhito ^a   Takemoto, Kazunori ^a   Abe, Ken Ichi ^a   Dansako, Hiromichi ^a   Ikeda, Masanori ^a   Shimotohno, Kunitada ^b   Kato, Nobuyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; GENE DISRUPTION; GENETIC DISORDER; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPLICON; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; VIRUS RESISTANCE; VIRUS VIRULENCE;

DRUG RESISTANCE, VIRAL; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERONS; MEMBRANE PROTEINS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON;

HEPATITIS C VIRUS;

EID: 26244455544     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81124-0     Document Type: Article

References (27)

1. Akagi, T., Shishido, T., Murata, K. & Hanafusa, H. (2000). v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc Natl Acad Sci U S A 97, 7290-7295.
2. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
3. Dansako, H., Naganuma, A., Nakamura, T., Ikeda, F., Nozaki, A. & Kato, N. (2003). Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res 97, 17-30.
4. Frese, M., Pietschmann, T., Moradpour, D., Haller, O. & Bartenschlager, R. (2001). Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82, 723-733.
5. Frese, M., Schwarzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O. & Bartenschlager, R. (2002). Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35, 694-703.
6. Hadziyannis, S. J., Sette, H., Jr, Morgan, T. R. & 11 other authors (2004). Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140, 346-355.
7. Hijikata, M., Mizushima, H., Tanji, Y., Komoda, Y., Hirowatari, Y., Akagi, T., Kato, N., Kimura, K. & Shimotohno, K. (1993). Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A 90, 10773-10777.
8. Ikeda, M., Yi, M., Li, K. & Lemon, S. M. (2002). Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76, 2997-3006.
9. Ikeda, M., Abe, K., Dansako, H., Nakamura, T., Naka, K. & Kato, N. (2005). Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 329, 1350-1359.
10. Kato, N. (2001). Molecular virology of hepatitis C virus. Acta Med Okayama 55, 133-159.
11. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T. & Shimotohno, K. (1990). Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 87, 9524-9528.
12. Kato, N., Sugiyama, K., Namba, K., Dansako, H., Nakamura, T., Takami, M., Naka, K., Nozaki, A. & Shimotohno, K. (2003). Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem Biophys Res Commun 306, 756-766.
13. Kato, N., Nakamura, T., Dansako, H., Namba, K., Abe, K., Nozaki, A., Naka, K., Ikeda, M. & Shimotohno, K. (2005). Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture. J Gen Virol 86, 645-656.
14. Kishine, H., Sugiyama, K., Hijikata, M. & 7 other authors (2002). Subgenomic replicon derived from a cell line infected with the hepatitis C virus. Biochem Biophys Res Commun 293, 993-999.
15. Kuo, G., Choo, Q. L., Alter, H. J. & 17 other authors (1989). An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362-364.
16. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. & Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113.
17. Machida, K., Cheng, K. T.-N., Sung, V. M.-H., Lee, K. J., Levine, A. M. & Lai, M. M. (2004a). Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78, 8835-8843.
18. Machida, K., Cheng, K. T.-N., Sung, V. A.-H., Shimodaira, S., Lindsay, K. L., Levine, A. M., Lai, M.-Y. & Lai, M. M. (2004b). Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 101, 4262-4267.
19. Naganuma, A., Nozaki, A., Tanaka, T., Sugiyama, K., Takagi, H., Mori, M., Shimotohno, K. & Kato, N. (2000). Activation of the interferon-inducible 2′-5′-oligoadenylate synthetase gene by hepatitis C virus core protein. J Virol 74, 8744-8750.
20. Naganuma, A., Dansako, H., Nakamura, T., Nozaki, A. & Kato, N. (2004). Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cells. Cancer Res 64, 1307-1314.
21. Naka, K, Ikeda, M., Abe, K., Dansako, H. & Kato, N. (2005). Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-α. Biochem Biophys Res Commun 330, 871-879.
22. Namba, K., Naka, K., Dansako, H., Nozaki, A., Ikeda, M., Shiratori, Y., Shimotohno, K. & Kato, N. (2004). Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype. Biochem Biophys Res Commun 323, 299-309.
23. Nozaki, A., Ikeda, M., Naganuma, A., Nakamura, T., Inudoh, M., Tanaka, K. & Kato, N. (2003). Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J Biol Chem 278, 10162-10173.
24. Pawlotsky, J. M. (2000). Hepatitis C virus resistance to antiviral therapy. Hepatology 32, 889-896.
25. Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W. & Yang, C. H. (1997). STAT3 as an adapter to couple phosphatidyl-inositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276, 1418-1420.
26. Saito, I., Miyamura, T., Ohbayashi, A. & 10 other authors (1990). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547-6549.
27. Thomas, D. L. (2000). Hepatitis C epidemiology. Curr Top Microbiol Immunol 242, 25-41.